Histopathology
Catalog entries using this tag (links open the entry card on its page):
Entries
CHIEF
PUBMED_LINK
FULL NAME
CHIEF — Clinical Histopathology Imaging Evaluation Foundation Model
DESCRIPTION
CHIEF (Clinical Histopathology Imaging Evaluation Foundation) is a general-purpose weakly supervised machine learning framework from Harvard Medical School. Trained on 60,530 WSIs spanning 19 anatomical sites (44TB data), CHIEF leverages two complementary pretraining methods: unsupervised pretraining for tile-level feature identification and weakly supervised pretraining for whole-slide pattern recognition. Validated on 19,491 WSIs from 32 independent slide sets across 24 hospitals internationally. Outperforms SOTA deep learning methods by up to 36.1%, demonstrating strong generalization across diverse populations and slide preparation methods.
URL
TITLE
A pathology foundation model for cancer diagnosis and prognosis prediction.
Main citation
Wang X, Zhao J, Marostica E, Yuan W, Jin J, Zhang Y, Wang F, Li Y, Yu KH, Baris T, Anand D, Hughes K, Rosemon J, Bower T, Lee S, Weerasinghe R, Wright BJ, Robicsek A, Piening B, Bifulco C, Wang S, Poon H. (2024) A pathology foundation model for cancer diagnosis and prognosis prediction. Nature, 634(8035):970-978. doi:10.1038/s41586-024-07894-z. PMID 39232164
ABSTRACT
Histopathology image evaluation is indispensable for cancer diagnoses and subtype classification. Standard AI methods for histopathology image analyses have focused on optimizing specialized models for each diagnostic task, often with limited generalizability. To address this challenge, we devised CHIEF, a general-purpose weakly supervised machine learning framework to extract pathology imaging features for systematic cancer evaluation. CHIEF leverages two complementary pretraining methods to extract diverse pathology representations: unsupervised pretraining for tile-level feature identification and weakly supervised pretraining for whole-slide pattern recognition. Developed using 60,530 whole-slide images spanning 19 anatomical sites, CHIEF outperformed SOTA deep learning methods by up to 36.1%, showing its ability to address domain shifts observed in samples from diverse populations.
DOI
10.1038/s41586-024-07894-z
CONCH
PUBMED_LINK
FULL NAME
CONCH — Contrastive learning from Captions for Histopathology (Vision-Language Foundation Model)
DESCRIPTION
CONCH (CONtrastive learning from Captions for Histopathology) is a vision-language foundation model from Mahmood Lab (Harvard/BWH). Pretrained on 1.17M histopathology image-text pairs from diverse sources (PubMed, educational resources, textbooks). Evaluated across 14 clinically relevant tasks including zero-shot cancer classification, text-to-image retrieval, image-to-text retrieval, caption generation, and tissue segmentation. Outperforms standard models including CLIP and PLIP. CONCH also works on non-H&E stains (IHC, special stains), demonstrating broad applicability. Available as an open-source model for academic use.
URL
TITLE
A visual-language foundation model for computational pathology.
Main citation
Lu MY, Chen B, Williamson DFK, Chen RJ, Liang I, Ding T, Jaume G, Odintsov I, Le LP, Gerber G, Parwani AV, Zhang A, Mahmood F. (2024) A visual-language foundation model for computational pathology. Nature Medicine, 30(3):863-874. doi:10.1038/s41591-024-02856-4. PMID 38504017
ABSTRACT
We introduce CONCH, a visual-language foundation model developed using diverse sources of histopathology images and text. Trained on 1.17 million pathology image-text pairs, CONCH achieves state-of-the-art performance across 14 clinically relevant tasks, including zero-shot cancer classification, text-to-image and image-to-text retrieval, caption generation, and tissue segmentation. CONCH outperforms standard models like CLIP and PLIP, and generalizes to non-H&E stains including immunohistochemistry and special stains, demonstrating its versatility as a foundation model for computational pathology.
DOI
10.1038/s41591-024-02856-4
ENLIGHT-DeepPT
PUBMED_LINK
FULL NAME
ENLIGHT-DeepPT — Deep-Learning Framework for Cancer Treatment Response from Histopathology Images
DESCRIPTION
ENLIGHT-DeepPT (Deep Phenotyping of Tumors) is a deep-learning framework (ResNet50 + MLP) that predicts genome-wide tumor mRNA expression from routine H&E histopathology images across 16 TCGA cancer types. The imputed transcriptomics then drive treatment response prediction, achieving odds ratio of 2.28 across 5 independent treatment cohorts. Directly links medical imaging (histopathology) with genomics/transcriptomics via AI, enabling precision oncology from standard pathology slides.
TITLE
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.
Main citation
Hoang DT, Shulman ED, Shuaib M, Nguyen JD, Maqbool HH, Nguyen Q, Iyer P, Liu S, Ruppin E, Stone EA. (2024) A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics. Nature Cancer, 5(9):1305-1317. doi:10.1038/s43018-024-00793-2. PMID 38961276
ABSTRACT
Predicting cancer treatment response from routinely collected clinical material is a central challenge in precision oncology. Here we present ENLIGHT-DeepPT, a deep-learning framework that predicts genome-wide tumor mRNA expression from routine H&E histopathology images. Using a two-stage approach (image-to-transcriptomics via ResNet50 + MLP, then transcriptomics-to-treatment response), ENLIGHT-DeepPT achieves an odds ratio of 2.28 across 5 independent treatment cohorts spanning multiple cancer types and drug classes.
DOI
10.1038/s43018-024-00793-2